InfuSystem Holdings Inc

InfuSystem Holdings Inc Stock Forecast & Price Prediction

Live InfuSystem Holdings Inc Stock (INFU) Price
$8.93

0

Ratings

  • Buy 0
  • Hold 0
  • Sell 0
Disclaimer : Analyst ratings and price forecasts are sourced from Wall St analysts and other experts. These projections are speculative and do not guarantee future stock performance. This information is for educational purposes only and should not be construed as advice to buy or sell any security.

Stock Price

$8.93

P/E Ratio

135.86

Volume Traded Today

$115,400

Dividend

Dividends not available for INFU

52 Week High/low

10.99/5.74

InfuSystem Holdings Inc Market Cap

$202.7M

๐Ÿ›‘ Alert: These ten stocks could have higher potential than $INFU ๐Ÿ›‘

Before you buy INFU you'll want to see this list of ten stocks that have huge potential. Want to see if INFU made the cut? Enter your email below

INFU Summary

Based on ratings from 0 stock analysts, the InfuSystem Holdings Inc stock price is expected to increase by 58.23% in 12 months. This is calculated by using the average 12-month stock price forecast for InfuSystem Holdings Inc. The lowest target is $12.5 and the highest is $15. Please note analyst price targets are not guaranteed and could be missed completely.

INFU Analyst Ratings

InfuSystem Holdings Inc has a total of 0 Wall St Analyst ratings. There are 0 buy ratings, 0 ratings, and 0 sell ratings. Since most analysts have a sell consensus rating, the expectation is that InfuSystem Holdings Inc will perform worse than the market. Investors shouldn't rely purely on analyst ratings; we encourage investors to also take a look at the fundamental and technical analysis in their due diligence.

INFU stock forecast by analyst

These are the latest 20 analyst ratings of INFU.

Analyst/Firm

Rating

Price Target

Change

Date


B. Riley Securities

Buy

$13

Initiates

Sep 26, 2024
James Terwilliger
Northland Capital Markets

Outperform

$27

Initiates

Apr 26, 2021

Craig-Hallum

Buy


Initiates

Aug 31, 2020

INFU Company Information

What They Do: Provides infusion pumps and related services.

Business Model: The company operates through two segments: Patient Services and Device Solutions. It generates revenue by supplying electronic ambulatory infusion pumps and disposable supply kits primarily to oncology clinics, as well as by selling, renting, and leasing medical equipment. Additional income is derived from selling treatment-related consumables and providing maintenance and repair services to various healthcare facilities.

Other Information: Incorporated in 2005 and headquartered in Rochester Hills, Michigan, the company also emphasizes customer support and operates service and repair centers for their equipment. Its focus on oncology and pain management positions it in a niche market with steady demand.
INFU
InfuSystem Holdings Inc (INFU)

When did it IPO

2007

Staff Count

499

Country

United States

Sector/Industry

Healthcare/Medical Instruments & Supplies

CEO

Mr. Richard A. DiIorio

Market Cap

$202.7M

InfuSystem Holdings Inc (INFU) Financial Data

In 2023, INFU generated $125.8M in revenue, which was a increase of 14.44% from the previous year. This can be seen as a signal that INFU's business is growing, and its share price could be worth more in the future. However, if the company grows faster (or slower) than expected, this could also have a major impact on the future share price.

Revenue From 2020

$97.4M

Revenue From 2021

$102.4M

5.13 %
From Previous Year

Revenue From 2022

$109.9M

7.36 %
From Previous Year

Revenue From 2023

$125.8M

14.44 %
From Previous Year
  • Revenue TTM $132.8M
  • Operating Margin TTM 9.2%
  • Gross profit TTM $63.1M
  • Return on assets TTM 3.3%
  • Return on equity TTM 2.8%
  • Profit Margin 1.1%
  • Book Value Per Share 2.61%
  • Market capitalisation $202.7M
  • Revenue for 2021 $102.4M
  • Revenue for 2022 $109.9M
  • Revenue for 2023 $125.8M
  • EPS this year (TTM) $0.07

InfuSystem Holdings Inc (INFU) Latest News

News Image

Sat, 09 Nov 2024

Sentiment - NEUTRAL

Source - Seeking Alpha

Summary - InfuSystem Holdings, Inc. will host its Q3 2024 financial results conference call on November 7, 2024, at 9:00 AM ET. Key executives will participate in the call.

Why It Matters - The Q3 2024 results call for InfuSystem provides insights into the company's financial health, growth prospects, and strategic direction, directly influencing investor sentiment and stock performance.

News Image

Thu, 07 Nov 2024

Sentiment - NEUTRAL

Source - Business Wire

Summary - InfuSystem has released its financial results for the third quarter of 2024. Further details can be found in their official report.

Why It Matters - InfuSystem's Q3 2024 financial results provide insights into its performance, affecting stock valuations and investor confidence based on revenue growth, profitability, and market position.

News Image

Thu, 31 Oct 2024

Sentiment - NEUTRAL

Source - Business Wire

Summary - InfuSystem will announce its third quarter 2024 financial results on November 7, 2024.

Why It Matters - The scheduled financial results report can influence investor sentiment, potentially impacting stock price and trading volume based on performance expectations.

News Image

Thu, 10 Oct 2024

Sentiment - POSITIVE

Source - MarketBeat

Summary - The medical device market is expected to surpass $600 billion by 2025, driven by an aging population, rising healthcare costs, and advancements in AI and biotechnology.

Why It Matters - Projected growth of the medical device market to over $600 billion indicates strong investment potential, driven by demographic trends and technological innovations, signaling robust opportunities for profit.

News Image

Fri, 27 Sep 2024

Sentiment - NEUTRAL

Source - Business Wire

Summary - InfuSystem will participate in the Lytham Partners Fall 2024 Investor Conference on October 1, 2024, providing an opportunity for investor engagement.

Why It Matters - InfuSystem's participation in the Lytham Partners Fall 2024 Investor Conference signals potential visibility and engagement with investors, which may impact stock performance and investor interest.

News Image

Wed, 11 Sep 2024

Sentiment - NEUTRAL

Source - Business Wire

Summary - InfuSystem Holdings, Inc. and Sanara MedTech have signed an exclusive U.S. distribution agreement with ChemoMouthpiece, LLC, enhancing their outpatient care offerings.

Why It Matters - The exclusive distribution agreement with ChemoMouthpiece expands InfuSystem's service offerings, potentially increasing revenue streams and market share, which can positively impact stock performance.

...

INFU Frequently asked questions

The highest forecasted price for INFU is $15 from at .

The lowest forecasted price for INFU is $12.5 from from

The INFU analyst ratings consensus are 0 buy ratings, 0 hold ratings, and 0 sell ratings.